Evidence map›Paper›PMID 39610660›Full record

ArticleKnowledge-based systems2024

HeteroKGRep: Heterogeneous Knowledge Graph based Drug Repositioning.

Ribot Fleury T Ceskoutsé, Alain Bertrand Bomgni, David R Gnimpieba Zanfack, Diing D M Agany, Bouetou Bouetou Thomas, Etienne Gnimpieba Zohim

Abstract read
In one paragraph

Article in Knowledge-based systems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ribot Fleury T CeskoutséEcole Nationale Supérieure Polytechnique, University of Yaounde I, P.O. Box. 8390, Yaoundé, Cameroon.
Alain Bertrand BomgniUniversity of South Dakota, 4800 N Career Avenue, 57107, SD, USA.
David R Gnimpieba ZanfackLaboratory of Innovative Technologies (LTI), University of Picardie Jule Verne (UPJV), 48 Rue Raspail, 02100 Saint Quentin, France.
Diing D M AganyUniversity of South Dakota, 4800 N Career Avenue, 57107, SD, USA.
Bouetou Bouetou ThomasEcole Nationale Supérieure Polytechnique, University of Yaounde I, P.O. Box. 8390, Yaoundé, Cameroon.
Etienne Gnimpieba ZohimUniversity of South Dakota, 4800 N Career Avenue, 57107, SD, USA.

Funding

Wichozani-A Healthy Lifestyle for Rural American Indian Youth through Cultural and Physical Activities: A Community-Based Participatory Research StudyP20GM103443 · NIGMS · UNIVERSITY OF SOUTH DAKOTA · PI Victor Chester Huber · 2012 to 2026
$58.1M
NIGMS NIH HHS P20 GM103443
6 · The paper itself

Abstract

The process of developing new drugs is both time-consuming and costly, often taking over a decade and billions of dollars to obtain regulatory approval. Additionally, the complexity of patent protection for novel compounds presents challenges for pharmaceutical innovation. Drug repositioning offers an alternative strategy to uncover new therapeutic uses for existing medicines. Previous repositioning models have been limited by their reliance on homogeneous data sources, failing to leverage the rich information available in heterogeneous biomedical knowledge graphs. We propose HeteroKGRep, a novel drug repositioning model that utilizes heterogeneous graphs to address these limitations. HeteroKGRep is a multi-step framework that first generates a similarity graph from hierarchical concept relations. It then applies SMOTE over-sampling to address class imbalance before generating node sequences using a heterogeneous graph neural network. Drug and disease embeddings are extracted from the network and used for prediction. We evaluated HeteroKGRep on a graph containing biomedical concepts and relations from ontologies, pathways and literature. It achieved state-of-the-art performance with 99% accuracy, 95% AUC ROC and 94% average precision on predicting repurposing opportunities. Compared to existing homogeneous approaches, HeteroKGRep leverages diverse knowledge sources to enrich representation learning. Based on heterogeneous graphs, HeteroKGRep can discover new drug-desease associations, leveraging de novo drug development. This work establishes a promising new paradigm for knowledge-guided drug repositioning using multimodal biomedical data.

Indexed as

biomedical heterogeneous graphdeep learningdrug repurposing

Identifiers

PMID39610660
PMCPMC11600970

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.